Ziopharm Oncology
ZIOP
#8631
Rank
HK$1.46 B
Marketcap
HK$6.82
Share price
-0.88%
Change (1 day)
-74.68%
Change (1 year)

Earnings for Ziopharm Oncology (ZIOP)

Earnings in 2021 (TTM): -HK$0.7 Billion

According to Ziopharm Oncology's latest financial reports the company's current earnings are HK$3.73 Million. In 2020 the company made an earning of -HK$0.63 Billion a decrease over its 2019 earnings that were of -HK$0.46 Billion.

Earnings history for Ziopharm Oncology from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-HK$0.7 Billion10.12%
2020-HK$0.63 Billion38.89%
2019-HK$0.46 Billion7.33%
2018-HK$0.43 Billion0.77%
2017-HK$0.42 Billion-67.64%
2016-HK$1.3 Billion37.64%
2015-HK$0.95 Billion176.1%
2014-HK$0.35 Billion-24.63%
2013-HK$0.46 Billion-43.51%
2012-HK$0.81 Billion43.09%
2011-HK$0.56 Billion190.88%
2010-HK$0.2 Billion102.46%
2009-HK$95.02 Million-52.68%
2008-HK$0.21 Billion-10.33%
2007-HK$0.23 Billion15.35%
2006-HK$0.2 Billion355.36%
2005-HK$42.64 Million13788.35%
2004-HK$0.31 Million9.27%
2003-HK$0.29 Million-10.26%
2002-HK$0.32 Million-59.35%
2001-HK$0.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
HK$70.34 B-10,154.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-HK$3.96 Billion 465.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$73.10 B-10,548.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-HK$21.58 Million-96.92%๐Ÿ‡บ๐Ÿ‡ธ USA